Lepidopteran-active Cry1Da1 amino acid sequence variant proteins

US10457958B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10457958-B2
Application numberUS-201816047187-A
CountryUS
Kind codeB2
Filing dateJul 27, 2018
Priority dateOct 16, 2014
Publication dateOct 29, 2019
Grant dateOct 29, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Engineered Cry1Da amino acid sequences are provided that exhibit improved Lepidopteran insecticidal activity and an enhanced Lepidopteran spectrum compared to the naturally occurring Cry1Da protein toxin. Polynucleotide sequences intended for use in expression of the improved proteins in plants are also provided. Particular embodiments provide compositions containing insect inhibitory amounts of the engineered proteins, as well as recombinant plants, plant parts, and seeds containing polynucleotide constructs encoding one or more of the improved engineered proteins.

First claim

Opening claim text (preview).

What is claimed is: 1. An engineered insecticidal protein comprising the amino acid sequence as set forth in SEQ ID NO:42. 2. The engineered insecticidal protein of claim 1 , encoded by a polynucleotide operably linked to a heterologous promoter. 3. The engineered insecticidal protein of claim 1 , wherein said engineered insecticidal protein is encoded by a polynucleotide comprising a nucleotide sequence that hybridizes to the reverse complement of the polynucleotide sequence as set forth in SEQ ID NO:41. 4. A host cell comprising the polynucleotide of SEQ ID NO:41, wherein said host cell is selected from the group consisting of a bacterial host cell and a plant host cell. 5. The host cell of claim 4 , wherein said bacterial host cell is selected from the group consisting of Agrobacterium, Rhizobium, Bacillus, Brevibacillus, Escherichia, Pseudomonas, Klebsiella , and Erwinia. 6. The plant host cell of claim 4 , wherein said plant host cell is selected from the group consisting of a monocot plant cell and a dicot plant cell. 7. An insect inhibitory composition comprising the engineered insecticidal protein of claim 1 , wherein said protein is present in an insect inhibitory amount. 8. The insect inhibitory composition of claim 7 , wherein said composition further comprises a second insect inhibitory agent different from said engineered insecticidal protein. 9. The insect inhibitory composition of claim 8 , wherein said second insect inhibitory agent is selected from the group consisting of an insect inhibitory protein and an insect inhibitory dsRNA molecule. 10. The insect inhibitory composition of claim 9 , wherein said second pesticidal agent exhibits activity against one or more pest species selected from the group of orders consisting of Lepidoptera, Coleoptera, Hemiptera, Homoptera, and Thysanoptera. 11. A seed comprising the full length polynucleotide set forth in SEQ ID NO: 41, wherein said polynucleotide is operably linked to a heterologous promoter. 12. A method of controlling a Lepidopteran pest comprising contacting said Lepidopteran pest with an insect inhibitory amount of the engineered insecticidal protein of claim 1 . 13. A transgenic plant or plant part comprising the engineered insecticidal protein of claim 1 and a polynucleotide having the nucleotide sequence as set forth in SEQ ID NO:41, wherein said engineered insecticidal protein is present in an insect inhibitory amount. 14. A method of controlling a Lepidopteran pest, said method comprising exposing said pest to the transgenic plant or plant part of claim 13 . 15. A commodity product comprising a detectable amount of the engineered insecticidal protein of claim 1 or a detectable amount of a polynucleotide having the sequence as set forth in SEQ ID NO:41. 16. The commodity product of claim 15 , wherein said commodity product is selected from the group consisting of plant biomass, oil, meal, animal feed, flour, flakes, bran, lint, hulls, and processed seed. 17. A method of producing a seed comprising the engineered insecticidal protein of claim 1 , the method comprising: a. planting at least one seed comprising a polynucleotide having the sequence as set forth in SEQ ID NO:41; b. growing a plant from said seed; and c. harvesting progeny seed from said plant, wherein said harvested seed comprises said polynucleotide.

Assignees

Inventors

Classifications

  • A01N47/08Primary

    the carbon atom having one or more single bonds to nitrogen atoms · CPC title

  • for insect resistance · CPC title

  • C07K14/325Primary

    Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins · CPC title

  • Human Necessities · mapped topic

  • Cross-Sectional Technologies · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10457958B2 cover?
Engineered Cry1Da amino acid sequences are provided that exhibit improved Lepidopteran insecticidal activity and an enhanced Lepidopteran spectrum compared to the naturally occurring Cry1Da protein toxin. Polynucleotide sequences intended for use in expression of the improved proteins in plants are also provided. Particular embodiments provide compositions containing insect inhibitory amounts o…
Who is the assignee on this patent?
Monsanto Technology Llc
What technology area does this patent fall under?
Primary CPC classification A01N47/08. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).